John D. Arnold
Centaurus Energy LP John D. Arnold is the founder and manger of the energy hedge fund Centaurus Energy LP. Mr. Arnold graduated from Vanderbilt University and began his career as a trader at Enron. Using the internet, he made $750 million for Enron in 2001 and was rewarded with an $8 million bonus.
After Enron collapsed in 2002, Arnold started Centaurus Energy with his $8 million bonus. Centaurus now has as much as $3 billion in assets under management. Many of the fund's employees are former Enron employees including former CEO, Greg Whalley. According to Forbes, Arnold is worth about $1.5 billion making him the 317 richest person in the world. At age 33, he holds the distinction of being the youngest billionaire on the 25th installment of the Forbes 400.
View Older Stories View More Recent Stories
-
Effort to repeat key cancer biology experiments reveals challenges and opportunities to improve replicability
-
Centaurus Energy Inc. Announces 2021 Third Quarter Financial Results and Operational Update
-
Centaurus Energy Enters Into Amendment to Agreement with Humble Energy, Settling Curamhuele-Related Liabilities Owed to Province of Neuquen for US$ 8MM
-
Energy and commods hedge funds post big gains as prices skyrocket
-
Centaurus Energy Enters into Agreement to Transfer All Conventional Oil and Gas Assets and Related Liabilities to Humble Energy
-
Centaurus Energy Inc. Announces 2021 Second Quarter Financial Results and Operational Update
-
Centaurus Energy Inc. Announces 2020 Financial Results and Operational Update
-
Centaurus Announces Extension of Management Cease Trade Order
-
Centaurus Provides Fourth Update on 2020 Annual Financial Statement Filings
-
CivicaScript, the Newly Named Civica Initiative to Serve Patients in Retail Markets, Announces a New Health Plan Partner, a New President, and a New Drug Manufacturing Partner
-
Centaurus Provides Third Update on 2020 Annual Financial Statement Filings
-
STATEMENT: Civica Rx Supports Biden Administration Recommendations for Strengthening the Pharmaceutical Supply Chain
-
Centaurus Provides Second Update on 2020 Annual Financial Statement Filings
-
Centaurus Energy Inc. Announces 2021 First Quarter Financial Results and Operational Update
-
Centaurus Provides Update On 2020 Annual Financial Statement Filings
-
Centaurus Announces Management Cease Trade Order
-
Centaurus Announces Sale of Working Interest in Coiron Amargo Sur Este to Pan American Energy and Provides Corporate Update
-
Default Announcement
-
Crown Point Terminates Merger Discussions with Centaurus
-
Hedge funds bet on oil's 'big comeback' after pandemic hobbles producers
-
Civica to Build an Essential Medicines Manufacturing Facility in Virginia
-
Centaurus Announces Grant of Options
-
Crown Point Energy and Centaurus Energy Enter into Term Sheet and Propose to Merge in a Stock-Based Business Combination to Create an Operationally Diversified, Financially Strong, Argentina-Focused O
-
Crown Point Energy and Centaurus Energy Enter into Term Sheet and Propose to Merge in a Stock-Based Business Combination to Create an Operationally Diversified, Financially Strong, Argentina-Focused O
-
Crown Point Energy and Centaurus Energy enter into Term Sheet and propose to merge in a stock-based business combination to Create an Operationally Diversified, Financially Strong, Argentina-focused o
-
Centaurus Energy Inc. Announces 2020 Third Quarter Financial Results and Operational Update
-
CMS Names ClosedLoop.ai a Finalist in $1.6 Million AI Health Challenge
-
National Police Foundation Releases Survey Results to Guide Law Enforcement Preparation for the 2020 Election
-
Centaurus Energy Inc. Announces 2020 Second Quarter Financial Results and Operational Update
-
Special Report: Big Pharma wages stealth war on drug price watchdog
-
Essential Medicines Company Civica Rx Turns 2, Marking Numerous Milestones
-
Centaurus Energy Inc. Announces Delayed Filing of Interim Disclosure Documents Under Temporary Covid-19 Relief Measures
-
A New Probabilistic Genotyping Standard From The American Academy Of Forensic Sciences Standards Board (ASB)
-
Kaiser Permanente Joins Forces with Civica Rx to Improve Availability and Affordability of Essential Generic Medications
-
Centaurus Energy Inc. Announces 2020 First Quarter Financial Results and Operational Update
-
Phlow Corporation Awarded $354 Million HHS/ASPR/BARDA Contract to Manufacture Essential Medicines in Shortage
-
hiSky Partners With ST Engineering iDirect to Enable IoT Over Satellite
-
First patients undergo new heart procedure at Blessing Health System
-
Civica Rx Partners with Thermo Fisher Scientific to Develop and Manufacture Drugs with a History of Drug Shortages
-
Waller Elects 14 Partners
-
More drugmakers hike U.S. prices as new year begins
-
Exclusive: Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs
-
Exclusive: Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs
-
Civica Rx and Hikma Announce Shipments of Heparin and Seven Other Essential Injectable Medicines
-
Patients Are Now Being Treated with a Civica Rx Medication
-
Civica Rx and Exela Pharma Sciences Join Forces to Provide Sodium Bicarbonate to Hospitals Across the U.S.
-
Medicare Part D plans have removed barriers to opioid use disorder medications
-
Medicare Part D plans have removed barriers to opioid use disorder medications

